|

Closed-loop Medtronic 780G System in Youth With Type 1 Diabetes

RECRUITINGSponsored by Sheba Medical Center
Actively Recruiting
SponsorSheba Medical Center
Started2023-06-01
Est. completion2026-07-01
Eligibility
Age1 Year – 21 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05908708

Summary

The goal of this observational study is to describe data on Israeli children and youth using the 780G system including data regarding glycemic control parameters, various questionnaires, sleep data, bioimpedance measures, and dietary parameters. The main questions it aims to answer are: • whether the 780G system will improve glycemic control • whether the psychosocial aspects will improve. Participants will be followed once connected to 780G, at baseline, one, three, six months, 1 year, and two years after the connection.

Eligibility

Age: 1 Year – 21 YearsHealthy volunteers accepted
Inclusion Criteria:

Diagnosis of type 1 diabetes Diabetes duration ≥ 6 months Routine attendance at clinic visits Initiation of 780G system usage

Exclusion Criteria:

Children under the age of 1 year Children without 780G system

Conditions3

Child, OnlyDiabetesType 1 Diabetes

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.